Archives
-
Mifepristone (RU486): Evidence Beyond Mechanism
2026-10-08
Mifepristone (RU486) is best understood through an evidence framework that connects progesterone-receptor biology with functional and transcriptomic outcomes. This article examines its reported oncology and reproductive applications while using human cardiomyocyte data to clarify translational strength, uncertainty, and study boundaries.
-
Merimepodib (VX-497) and IMPDH-Targeted Research
2026-10-07
Merimepodib (VX-497) is an IMPDH inhibitor used as a research probe of guanine nucleotide metabolism. This overview examines its immunological and antiviral research context, recent PEDV findings, evidence strength, provenance, and the limits of translating cell-based observations into therapeutic claims.
-
Rimonabant and the Next Wave of CB1 Research
2026-10-07
Rimonabant (SR141716) remains a valuable CB1 pathway probe for separating endocannabinoid signaling from emerging non-cannabinoid mechanisms, including adenosine A2A activity in terpene-mediated antinociception.
-
Baicalein: Evidence, Applications, and Limits
2026-10-06
Baicalein, also known as 5,6,7-trihydroxy-2-phenylchromen-4-one, is a flavonoid research compound associated with 12-LOX, arachidonic acid metabolism, cancer biology, apoptosis, and inflammation research. The supplied evidence supports a cautious, hypothesis-generating interpretation rather than clinical or translational conclusions. A recent formononetin study provides a useful comparison for study design, but it does not establish baicalein activity.
-
Dexamethasone Research Context and Evidence Limits
2026-10-06
This overview examines Dexamethasone as a glucocorticoid anti-inflammatory research tool alongside recent evidence on anti-inflammatory lignans from rosemary roots. It distinguishes supplier-described applications from peer-reviewed findings and outlines important limits on interpretation, model transferability, and comparative claims.
-
Bismuth Subsalicylate in GI Research: Evidence and Limits
2026-10-05
A source-grounded overview of Bismuth Subsalicylate research context, proposed gastrointestinal applications, annexin V assay interpretation, evidence gaps, and limits on translating supplier claims into scientific conclusions.
-
Phenytoin: PON1 Findings and Research Context
2026-10-05
Phenytoin is best understood through two related but distinct research contexts: sodium channel pharmacology and drug–enzyme interaction studies. This overview examines the reported in vitro inhibition of human paraoxonase-1, compares phenytoin with other antiepileptic drugs, and defines the evidence limits for electrophysiology, oxidative-stress, and neurological disease research.
-
Balsalazide for Active Ulcerative Colitis
2026-10-04
Wiggins and Rajapakse reviewed balsalazide as a colon-targeted 5-aminosalicylate prodrug for mild-to-moderate active ulcerative colitis. Their analysis highlights bacterial azoreduction, reported remission benefits over placebo and mesalamine, and a generally favorable tolerability profile, while also showing the limits of evidence available in 2009.
-
GRK Control of Biased M1 Receptor Signaling
2026-10-03
A 2025 study used dynamic BRET measurements to examine how GRK2/3 and GRK5/6 shape M1 receptor association with G proteins and β-arrestin 2. Its findings position BQCA as a mechanistically informative M1 allosteric modulator while showing that receptor-protein association patterns and downstream functional outcomes should not be treated as interchangeable.
-
Phenytoin Workflows for Sodium Channel Research
2026-10-02
Build reproducible sodium channel modulation studies with Phenytoin, from fresh-solution preparation and electrophysiology assay design to orthogonal enzyme-inhibition controls. The workflow also translates quantitative hPON1 findings into practical decisions about concentration ranges, solvent controls, and result interpretation.
-
Ruthenium Red for Mechanostress Autophagy
2026-10-01
Ruthenium Red is a water-compatible Ca2+ transport inhibitor for testing whether calcium flux connects mechanical compression, cytoskeletal organization, and autophagy. This application-focused guide combines the reference study’s force biology with practical calcium perturbation, controls, and troubleshooting for mitochondrial, sarcoplasmic-reticulum, and inflammation models.
-
Forskolin in Human Neuron Reactivation Models
2026-10-01
Forskolin is an adenylate cyclase activator that provides a mechanistic cAMP perturbation tool for human sensory-neuron models of HSV-1 latency. This article connects reagent handling, orthogonal reactivation endpoints, and stem-cell-derived neuron validation without confusing assay evidence across biological systems.
-
Benzyl Quinolone Carboxylic Acid for M1 Studies
2026-09-30
Benzyl Quinolone Carboxylic Acid (BQCA) enables selective probing of M1 muscarinic receptor potentiation, from concentration–response assays to GRK and β-arrestin signaling studies. This workflow-focused guide explains assay design, brain-relevant applications, and practical troubleshooting for reproducible acetylcholine receptor signaling experiments.
-
Pharmacogenomics of Chloroquine and Hydroxychloroquine
2026-09-30
This review synthesizes evidence that CYP2C8, CYP3A4/5, and CYP2D6 variation may alter chloroquine and hydroxychloroquine exposure, efficacy, and toxicity. Its main contribution is a risk-phenotype framework that connects ultra-rapid and poor metabolism with potentially important differences across patient populations, while highlighting the limited evidence base requiring prospective validation.
-
Patient-Derived Prostate Spheroid Cultures
2026-09-29
The reference study established viable three-dimensional spheroid cultures from radical prostatectomy specimens and showed that they retain clinically relevant epithelial and androgen-receptor features. Its drug-response experiments demonstrate the value of this organ-confined model for translational prostate cancer research, while also emphasizing that responses to steroidogenesis-directed agents must be interpreted in the context of compound identity and culture biology.